The U.S. Supreme Court will not hear an appeal from disgraced pharmaceutical executive Martin Shkreli, according to an order released by the justices Monday.

Shkreli’s 2017 conviction on securities fraud and conspiracy charges was upheld in a summary order from the U.S. Court of Appeals for the Second Circuit in July.